Cargando…

Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups

To generate hypotheses on possible sources of Shiga toxin-producing Escherichia coli (STEC) serogroup O80 associated hemolytic-uremic syndrome (HUS), we explored differences in factors associated with STEC O80 associated HUS, compared with STEC O157 or STEC of other serogroups, in France during 2013...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingelbeen, Brecht, Bruyand, Mathias, Mariani-Kurkjian, Patricia, Le Hello, Simon, Danis, Kostas, Sommen, Cécile, Bonacorsi, Stéphane, de Valk, Henriette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231688/
https://www.ncbi.nlm.nih.gov/pubmed/30419067
http://dx.doi.org/10.1371/journal.pone.0207492
_version_ 1783370279776419840
author Ingelbeen, Brecht
Bruyand, Mathias
Mariani-Kurkjian, Patricia
Le Hello, Simon
Danis, Kostas
Sommen, Cécile
Bonacorsi, Stéphane
de Valk, Henriette
author_facet Ingelbeen, Brecht
Bruyand, Mathias
Mariani-Kurkjian, Patricia
Le Hello, Simon
Danis, Kostas
Sommen, Cécile
Bonacorsi, Stéphane
de Valk, Henriette
author_sort Ingelbeen, Brecht
collection PubMed
description To generate hypotheses on possible sources of Shiga toxin-producing Escherichia coli (STEC) serogroup O80 associated hemolytic-uremic syndrome (HUS), we explored differences in factors associated with STEC O80 associated HUS, compared with STEC O157 or STEC of other serogroups, in France during 2013–16. STEC was isolated from 153/521 (30%) reported HUS cases: 45 serogroup O80, 46 O157 and 62 other serogroups. Median ages were 1.1 years, 4.0 years and 1.8 years, respectively. O80 infected patients were less likely to report ground beef consumption (aOR [adjusted Odds Ratio] 0.14 95% CI [Confidence Interval] 0.02–0.80) or previous contact with a person with diarrhea or HUS (aOR 0.13 95%CI 0.02–0.78) than patients infected with STEC O157. They were also less likely to report previous contact with a person presenting with diarrhea/HUS than patients infected with other serogroups (aOR 0.13 95%CI 0.02–0.78). STEC O80 spread all over France among young children less exposed to known risk factors of O157 or other STEC infections, suggesting the existence of different reservoirs and transmission patterns.
format Online
Article
Text
id pubmed-6231688
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62316882018-11-19 Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups Ingelbeen, Brecht Bruyand, Mathias Mariani-Kurkjian, Patricia Le Hello, Simon Danis, Kostas Sommen, Cécile Bonacorsi, Stéphane de Valk, Henriette PLoS One Research Article To generate hypotheses on possible sources of Shiga toxin-producing Escherichia coli (STEC) serogroup O80 associated hemolytic-uremic syndrome (HUS), we explored differences in factors associated with STEC O80 associated HUS, compared with STEC O157 or STEC of other serogroups, in France during 2013–16. STEC was isolated from 153/521 (30%) reported HUS cases: 45 serogroup O80, 46 O157 and 62 other serogroups. Median ages were 1.1 years, 4.0 years and 1.8 years, respectively. O80 infected patients were less likely to report ground beef consumption (aOR [adjusted Odds Ratio] 0.14 95% CI [Confidence Interval] 0.02–0.80) or previous contact with a person with diarrhea or HUS (aOR 0.13 95%CI 0.02–0.78) than patients infected with STEC O157. They were also less likely to report previous contact with a person presenting with diarrhea/HUS than patients infected with other serogroups (aOR 0.13 95%CI 0.02–0.78). STEC O80 spread all over France among young children less exposed to known risk factors of O157 or other STEC infections, suggesting the existence of different reservoirs and transmission patterns. Public Library of Science 2018-11-12 /pmc/articles/PMC6231688/ /pubmed/30419067 http://dx.doi.org/10.1371/journal.pone.0207492 Text en © 2018 Ingelbeen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ingelbeen, Brecht
Bruyand, Mathias
Mariani-Kurkjian, Patricia
Le Hello, Simon
Danis, Kostas
Sommen, Cécile
Bonacorsi, Stéphane
de Valk, Henriette
Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups
title Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups
title_full Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups
title_fullStr Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups
title_full_unstemmed Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups
title_short Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups
title_sort emerging shiga-toxin-producing escherichia coli serogroup o80 associated hemolytic and uremic syndrome in france, 2013-2016: differences with other serogroups
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231688/
https://www.ncbi.nlm.nih.gov/pubmed/30419067
http://dx.doi.org/10.1371/journal.pone.0207492
work_keys_str_mv AT ingelbeenbrecht emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups
AT bruyandmathias emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups
AT marianikurkjianpatricia emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups
AT lehellosimon emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups
AT daniskostas emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups
AT sommencecile emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups
AT bonacorsistephane emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups
AT devalkhenriette emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups